T0	Outcomes 185 246	efficacy, tolerability and first-dose blood-pressure response
T1	Outcomes 836 844	Efficacy
T2	Outcomes 849 857	assessed
T3	Outcomes 866 1069	six-minute walking test, the New York Heart Association (NYHA) class, a functional lifescale (FLS) questionnaire and the cardiothoracic ratio (CTR)-at study entry and at the end of the maintenance phase.
T4	Outcomes 1070 1084	Blood pressure
T5	Outcomes 1336 1395	distance walked during the six-minute walking test improved
T6	Outcomes 1464 1490	statistically significant.
T7	Outcomes 1505 1524	significant changes
T8	Outcomes 1532 1543	FLS or CTR.
T9	Outcomes 1624 1660	statistically significant difference
T10	Outcomes 1759 1770	hypotension
T11	Outcomes 1966 2001	first-dose blood-pressure response.